FDA warns Platinum Strategies
This article was originally published in The Tan Sheet
Executive SummaryFDA warns Platinum Strategies that several of its weight-loss products marketed as dietary supplements are unapproved prescription drugs because they include sibutramine - the active pharmaceutical ingredient in the obesity drug Meridia. In a Sept. 23 warning letter, FDA listsPineapple Fat Reducing Slimming Capsule, Tomato Slimming and other products as unapproved new prescription drugs. The agency also notes the firm's Web site has offered other products that contain sibutramine, including Starcaps. Several NFL players alleged Starcaps, made by Balanced Health Products, contained undeclared bumetanide, a diuretic banned by the league (1"The Tan Sheet" Dec. 1, 2008)
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.